Translational Research in Acute Lung Injury and Pulmonary Fibrosis Proresolving actions of a new resolvin D 1 analog mimetic qualifies as an immunoresolvent
暂无分享,去创建一个
[1] C. Serhan,et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.
[2] J. Uddin,et al. Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions* , 2006, Journal of Biological Chemistry.
[3] C. Serhan,et al. Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury , 2014, The Journal of Immunology.
[4] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[5] M. Toner,et al. Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution1 , 2008, The Journal of Immunology.
[6] J. Uddin,et al. Resolvin D1 and Its Aspirin-triggered 17R Epimer , 2007, Journal of Biological Chemistry.
[7] F. Gao,et al. Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat , 2012, The Journal of Immunology.
[8] M. Hersberger,et al. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation , 2013, Lipids in Health and Disease.
[9] J. K. Kundu,et al. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-&agr; expression , 2013, Journal of Cell Science.
[10] Takao Shimizu,et al. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. , 2000, The Journal of experimental medicine.
[11] B. Levy,et al. Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses , 2012, The Journal of Immunology.
[12] J. Palmblad,et al. Resolution of inflammation is altered in Alzheimer's disease , 2015, Alzheimer's & Dementia.
[13] V. Morandi,et al. ATL-1, a synthetic analog of lipoxin, modulates endothelial permeability and interaction with tumor cells through a VEGF-dependent mechanism. , 2014, Biochemical pharmacology.
[14] C. Serhan,et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. , 2012, The American journal of pathology.
[15] J. Filep,et al. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.
[16] S. Yoo,et al. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti‐nociception , 2010, British journal of pharmacology.
[17] J. Calixto,et al. Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice , 2011, The Journal of Immunology.
[18] C. Serhan,et al. Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.
[19] C. Klein,et al. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice , 2014, Neuropharmacology.
[20] Clay W Scott,et al. Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity , 2009, Journal of biomolecular screening.
[21] J. Parkinson,et al. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[22] C. Serhan,et al. Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.
[23] E. Anggard,et al. The Distribution of 15-Hydroxy Prosta-glandin Dehydrogenase and Prostaglandin-Δ13-Reductase in Tissues of the Swine , 1971 .
[24] Christian Weber,et al. Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013 .
[25] C. Serhan,et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.
[26] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[27] R. Dana,et al. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. , 2014, Investigative ophthalmology & visual science.
[28] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[29] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[30] C. Clish,et al. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] O. Baker,et al. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. , 2014, American journal of physiology. Cell physiology.
[32] C. Serhan,et al. Resolvins and protectins in inflammation resolution. , 2011, Chemical reviews.
[33] Trevor A. Mori,et al. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. , 2012, Clinical chemistry.
[34] C. Serhan,et al. Cutting Edge: Parathyroid Hormone Facilitates Macrophage Efferocytosis in Bone Marrow via Proresolving Mediators Resolvin D1 and Resolvin D2 , 2014, The Journal of Immunology.
[35] S. Freedman,et al. Resolvin D1 and Lipoxin A4 Improve Alveolarization and Normalize Septal Wall Thickness in a Neonatal Murine Model of Hyperoxia-Induced Lung Injury , 2014, PloS one.
[36] T. Eckle,et al. Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.
[37] Zhen-Zhong Xu,et al. Emerging targets in neuroinflammation-driven chronic pain , 2014, Nature Reviews Drug Discovery.
[38] M. Lindskog,et al. Aspirin‐triggered resolvin D1 prevents surgery‐induced cognitive decline , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] B. Levy,et al. Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.